Mounjaro (tirzepatide) Also a once-weekly injection, but tirzepatide targets both GLP-1 and GIP receptors a dual-action approach that has produced the strongest weight loss results seen in clinical trials to date (2025% average loss at the highest dose)
Available from: Dohil MA, Billman G, Pransky S, Eichenfield LF
Dig in to find a new favorite for you and your family
They improve cardiovascular health markers such as blood pressure and cholesterol levels
Infections: vulvovaginal candidiasis, bacterial vaginosis, vulvovaginitis Comparative observational signal (protective association): In a phenome-wide association study comparing people with type 2 diabetes prescribed GLP-1 receptor agonists vs SGLT2 inhibitors and DPP4 inhibitors (NIH All of Us cohort, Jan 2018Oct 2023), semaglutide prescription was associated with reduced risk of diagnoses including candidiasis of vulva and vagina and inflammatory disease of cervix, vagina, and vulva compared with SGLT2 inhibitors